Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches von Blauvelt, A., Lacour, J.‐P., Fowler, J.F., Weinberg, J.M., Gospodinov, D., Schuck, E., Jauch‐Lembach, J., Balfour, A., Leonardi, C.L.

Volltext

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3) von Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.

Volltext

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics von MENTER, Alan, GOTTLIEB, Alice, BEUTNER, Karl R, BHUSHAN, Reva, FELDMAN, Steven R, VAN VOORHEES, Abby S, LEONARDI, Craig L, GORDON, Kenneth B, LEBWOHL, Mark, KOO, John Y. M, ELMETS, Craig A, KORMAN, Neil J

Volltext

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based present... von MENTER, Alan, KORMAN, Neil J, LIM, Henry W, VAN VOORHEES, Abby S, BEUTNER, Karl R, RYAN, Caitriona, BHUSHAN, Reva, ELMETS, Craig A, FELDMAN, Steven R, GELFAND, Joel M, GORDON, Kenneth B, GOTTLIEB, Alice, KOO, John Y. M, LEBWOHL, Mark, LEONARDI, Craig L

Volltext

Extension of ustekinumab maintenance dosing interval in moderate‐to‐severe psoriasis: results of a phase IIIb, randomized, double‐blinded, active‐controlled, multicentre study (PST... von Blauvelt, A., Ferris, L.K., Yamauchi, P.S., Qureshi, A., Leonardi, C.L., Farahi, K., Fakharzadeh, S., Hsu, M.‐C., Li, S., Chevrier, M., Smith, K., Goyal, K., Chen, Y., Muñoz‐Elías, E.J., Callis Duffin, K.

Volltext

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 2. Psoriatic arthritis : Overview and guidelines of care for treatment with an emphasis on the bi... von GOTTLIEB, Alice, KORMAN, Neil J, BHUSHAN, Reva, MENTER, Alan, GORDON, Kenneth B, FELDMAN, Steven R, LEBWOHL, Mark, KOO, John Y. M, VAN VOORHEES, Abby S, ELMETS, Craig A, LEONARDI, Craig L, BEUTNER, Karl R

Volltext

Etanercept as Monotherapy in Patients with Psoriasis von Leonardi, Craig L, Powers, Jerold L, Matheson, Robert T, Goffe, Bernard S, Zitnik, Ralph, Wang, Andrea, Gottlieb, Alice B

Volltext

Efalizumab: an overview von Leonardi, Craig L

Volltext

Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial von Leonardi, Craig L., Papp, Kim A., Gordon, Kenneth B., Menter, Alan, Feldman, Steven R., Caro, Ivor, Walicke, Patricia A., Compton, Peter G., Gottlieb, Alice B.

Volltext

Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: Updated results from an ongoing trial von Gottlieb, Alice B., Hamilton, Tiffani, Caro, Ivor, Kwon, Paul, Compton, Peter G., Leonardi, Craig L.

Volltext

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3) von Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.

Volltext

Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database von Gottlieb, Alice B., Leonardi, Craig L., Goffe, Bernard S., Ortonne, Jean-Paul, van der Kerkhof, Peter C.M., Zitnik, Ralph, Nakanishi, Arline, Jahreis, Angelika

Volltext

The tumour necrosis factor-α inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques von Gordon, K.B., Bonish, B.K., Patel, T., Leonardi, C.L., Nickoloff, B.J.

Volltext

Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy von Gordon, Kenneth B., Gottlieb, Alice B., Leonardi, Craig L., Elewski, Boni E., Wang, Andrea, Jahreis, Angelika, Zitnik, Ralph

Volltext

Long-term management of plaque psoriasis with continuous efalizumab therapy von Menter, Alan, Leonardi, Craig L., Sterry, Wolfram, Bos, Jan D., Papp, Kim A.

Volltext

A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach von Strober, Bruce, MD, PhD, Berger, Emily, MD, Cather, Jennifer, MD, Cohen, David, MD, MPH, Crowley, Jeffrey J., MD, Gordon, Kenneth B., MD, Gottlieb, Alice, MD, PhD, Horn, Elizabeth J., PhD, Kavanaugh, Arthur F., MD, Korman, Neal J., MD, PhD, Krueger, Gerald G., MD, Leonardi, Craig L., MD, Menter, Alan, MD, Schwartzman, Sergio, MD, Sobell, Jeffrey M., MD, Young, Melodie, MSN, RN, A/GNP-c

Volltext

Secukinumab's Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment von Van de Kerkhof, PCM, Reich, K, Leonardi, CL, Blauvelt, A, Mehta, NN, Tsai, TF, You, R, Papanastasiou, P, Milutinovic, M, Griffiths, CEM

Volltext

Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis von Papp, Kim A., Miller, Bruce, Gordon, Kenneth B., Caro, Ivor, Kwon, Paul, Compton, Peter G., Leonardi, Craig L.

Volltext

伊赛珠单抗对银屑病的治疗:三项双盲对照研究的综合药效分析(发现‐1、发现‐2、发现‐3) von Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.

Volltext

Practical guidelines for the long-term treatment of psoriasis with efalizumab von Leonardi, Craig L., Papp, Kim A., Bos, Jan D.

Volltext